Jennifer Tousignant - 03 Mar 2025 Form 4/A - Amendment Insider Report for Viridian Therapeutics, Inc.\DE (VRDN)

Role: Chief Legal Officer
Signature: /s/Jennifer Tousignant
Issuer symbol: VRDN
Transactions as of: 03 Mar 2025
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 04 Mar 2026, 19:10:52 UTC
Date Of Original Report: 04 Mar 2025
Previous filing: 14 Feb 2024
Next filing: 02 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Tousignant Jennifer	Chief Legal Officer	C/O VIRIDIAN THERAPEUTICS, INC., 221 CRESCENT STREET, SUITE 103A, WALTHAM	/s/Jennifer Tousignant	04 Mar 2026	0002010978

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	VRDN	Common Stock						610	03 Mar 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This amendment is being filed to correct the number of shares beneficially owned by the Reporting Person as reported in the original Form 4 filed with the Securities and Exchange Commission on March 4, 2025, which inadvertently omitted an aggregate of 610 shares purchased under the Viridian Therapeutics, Inc. 2016 Employee Stock Purchase Plan.